Druggability Evaluation of the Neuron Derived Orphan Receptor (NOR‐1) Reveals Inverse NOR‐1 Agonists
Daniel Zaienne(Goethe University Frankfurt), Daniel Merk(Ludwig-Maximilians-Universität München), Jan Heering(Fraunhofer Institute for Translational Medicine and Pharmacology), Silvia Arifi(Goethe University Frankfurt), Julian A. Marschner(Ludwig-Maximilians-Universität München)
Cited by 11
Related Papers
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
The Medicinal Chemistry of Caffeine
|Journal of Medicinal Chemistry|2021|116
<scp>l</scp>-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ
|Journal of Medicinal Chemistry|2020|49
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation
|Journal of the American Chemical Society|2023|49
Nurr1 Modulation Mediates Neuroprotective Effects of Statins
|Advanced Science|2022|38